MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/bdra.23012

Медицинская библиотека · Birth defects research. Part A, Clinical and molecular teratology · 2012

Pharmacologic treatment of hyperthyroidism during pregnancy.

Cassina Matteo, Donà Marta, Di Gianantonio Elena, Clementi Maurizio

СтатьяОбзорПеревод в очереди

Аннотация

Clinical hyperthyroidism has been associated with an increased risk of maternal, fetal, and neonatal complications. The available antithyroid drugs are methimazole/carbimazole and propylthiouracil. Several case reports and some epidemiologic studies suggest that methimazole/carbimazole exposure during the first trimester of pregnancy is associated with an increased risk of congenital malformations, including ectodermal anomalies, choanal atresia, esophageal atresia, and omphalocele. However, the absolute risk appears to be very small, and it remains unclear whether the association is driven by the maternal disease, the medication, or the combination of both factors. Propylthiouracil exposure has not been associated with an increased risk of congenital malformations and is the recommended drug during the first trimester of pregnancy. Since propylthiouracil-induced hepatotoxicity has been reported in approximately 0.1% of exposed adults and the number of case-reports of severe liver injury is increasing, treatment with low dose methimazole during the second and third trimesters should be considered. Until now, there has been no evidence that children prenatally exposed to methimazole/carbimazole or propylthiouracil have an increased risk of neurodevelopmental delay.

Для цитирования: Cassina Matteo, Donà Marta, Di Gianantonio Elena, Clementi Maurizio. Pharmacologic treatment of hyperthyroidism during pregnancy.. Birth defects research. Part A, Clinical and molecular teratology. 2012. DOI: 10.1002/bdra.23012.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.